Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Carme Plasencia
Institution:
Applied Research Using OMIC Sciences (Spain)
Observed institution:
Applied Research Using OMIC Sciences (Spain)
ORCID:
0000-0002-2868-8850
Observed ORCID:
0000-0002-2868-8850
OpenAlex ID:
A5077974291
Anti-Tumor Functions of Prelatent Antithrombin on Glioblastoma Multiforme Cells
2021
·
Julia Peñas-Martínez
, Ginés Luengo-Gil
, et al.
·
Biomedicines
·
7
PDF
Methodological challenges in outcomes research for early-trials for implementation of new therapies in neuropediatric rare diseases
2025
·
Maria T. Acosta
, Silvia Zaragoza Domingo
, et al.
·
Orphanet Journal of Rare Diseases
·
2
PDF
Outcome strategies for clinical trials in Neuropaediatric rare diseases
2026
·
Maria Teresa Acosta
, José Ángel Aibar
, et al.
·
Neuroscience Applied
First in human phase 1 dose escalation and expansion clinical trial to evaluate the safety, pharmacokinetics and antitumor activity of intravenous AROG4-01 in patients with advanced solid tumors.
2025
·
Sonia Macia
, Vicente Valenti
, et al.
·
Journal of Clinical Oncology
Abstract CT120: First in human phase 1 dose escalation and expansion clinical trial to evaluate the safety, pharmacokinetics and antitumor activity of intravenous AROG4-01 in patients with advanced solid tumors
2025
·
Vicente Valentí
, María Jove
, et al.
·
Cancer Research
Show more works
View as search
Works count:
5
Citation count:
9
H-index:
2
I10-index:
Year
Topic
Type